BioMed Research International, 2015 · DOI: http://dx.doi.org/10.1155/2015/752572 · Published: July 22, 2015
Spinal cord injuries (SCI) often result in permanent loss of motor function due to the failure of neuronal connections to repair themselves. Post-injury, the spinal cord environment becomes inhibitory to neural regeneration. This review explores the use of biomaterials in therapeutic treatments to overcome this inhibitory environment and enhance functional recovery. Current SCI treatments focus on enhancing neuronal survival, regenerating damaged axons, and promoting neuroplasticity. However, no single therapy has been found to reverse SCI damage due to the spinal cord's complexity. Researchers need to consider the biological implications of each therapy in conjunction with the inherent response to SCI. The review discusses the challenges posed by the post-injury response of the spinal cord, current strategies for functional repair, and the potential use of biomaterials in aiding the recovery process. It emphasizes the importance of understanding the inherent biological response of the central nervous system (CNS) to both injury and subsequent therapeutic interventions.
The review identifies key molecular targets (CSPGs, myelin debris, Rho/ROCK pathway) for therapeutic intervention to promote axonal regeneration and functional recovery after SCI.
Highlights crucial considerations for designing biomaterials for SCI repair, guiding the development of more effective scaffolds, hydrogels, and nanoparticles for drug delivery and tissue support.
The need for combination therapies that simultaneously address multiple aspects of SCI pathology, paving the way for personalized treatment strategies that combine neurotrophic factors, inhibitory molecule neutralization, and biomaterial support.